These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis. Shinji S; Naito Z; Ishiwata T; Tanaka N; Furukawa K; Suzuki H; Seya T; Kan H; Tsuruta H; Matsumoto S; Matsuda A; Teranishi N; Ohaki Y; Tajiri T Int J Oncol; 2006 Aug; 29(2):357-64. PubMed ID: 16820877 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers. Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908 [TBL] [Abstract][Full Text] [Related]
7. The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium. Taraif SH; Deavers MT; Malpica A; Silva EG Int J Gynecol Pathol; 2009 Mar; 28(2):142-7. PubMed ID: 19188820 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and ultrastructural features of neuroendocrine differentiated carcinomas of the prostate: an immunoelectron microscopic study. Hirano D; Jike T; Okada Y; Minei S; Sugimoto S; Yamaguchi K; Yoshikawa T; Hachiya T; Yoshida T; Takimoto Y Ultrastruct Pathol; 2005; 29(5):367-75. PubMed ID: 16257863 [TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical and morphometric studies on neuroendocrine differentiation of prostate carcinomas]. Bohrer MH; Schmoll J Verh Dtsch Ges Pathol; 1993; 77():107-10. PubMed ID: 7511265 [TBL] [Abstract][Full Text] [Related]
10. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Blobel GA; Gould VE; Moll R; Lee I; Huszar M; Geiger B; Franke WW Lab Invest; 1985 Jan; 52(1):39-51. PubMed ID: 2981372 [TBL] [Abstract][Full Text] [Related]
11. The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon. Foley EF; Gaffey MJ; Frierson HF Arch Pathol Lab Med; 1998 Oct; 122(10):912-4. PubMed ID: 9786353 [TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine carcinomas of the breast. Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937 [TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study. Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133 [TBL] [Abstract][Full Text] [Related]
14. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716 [TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience. Saclarides TJ; Szeluga D; Staren ED Dis Colon Rectum; 1994 Jul; 37(7):635-42. PubMed ID: 8026228 [TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Papotti M; Macrì L; Finzi G; Capella C; Eusebi V; Bussolati G Semin Diagn Pathol; 1989 May; 6(2):174-88. PubMed ID: 2503862 [TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490 [TBL] [Abstract][Full Text] [Related]
18. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522 [TBL] [Abstract][Full Text] [Related]
19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793 [TBL] [Abstract][Full Text] [Related]
20. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer. Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]